Related Experiment Video
Updated: Aug 14, 2026
08:26
Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
Imaging drug resistance with radiolabeled molecules
1Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA. ganesan.v@duke.edu
Current Pharmaceutical Design
|September 24, 2004
Summary
Drug resistance in cancer chemotherapy is a major hurdle. This review explores radioactive probes for imaging drug efflux pumps and DNA repair proteins, aiding personalized cancer treatment strategies.
Area of Science:
- Oncology
- Radiochemistry
- Molecular Biology
Background:
- Cancer chemotherapy faces significant challenges due to drug resistance.
- Multidrug resistance (MDR) involves efflux pumps like P-glycoprotein (P-gp) and MRPs.
- Resistance to alkylating agents involves the DNA repair protein AGT, which removes drug-induced DNA damage.
Purpose of the Study:
- To review the development of radioactive probes for cancer chemotherapy resistance.
- To enable noninvasive monitoring of drug efflux pumps and AGT levels in tumors.
- To support patient-specific optimization of chemotherapy protocols.
Main Methods:
- Synthesis of novel radioactive probes targeting key resistance mechanisms.
- Application of radionuclide imaging techniques for quantitation.
- Correlation of imaging data with cellular resistance markers.
Main Results:
- Radioactive probes have been successfully synthesized to target MDR-associated transporters and AGT.
- Radionuclide imaging allows for noninvasive assessment of these resistance factors in vivo.
- These imaging tools provide insights into the dynamics of chemotherapy resistance.
Conclusions:
- Noninvasive imaging of drug efflux pumps and AGT holds promise for personalized cancer therapy.
- Radioactive probes can guide treatment decisions by quantifying resistance mechanisms.
- Further development of these probes will enhance our understanding and management of cancer drug resistance.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET